Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly

Area of Science:

• Gerontology
• Cardiology
• Pharmacology

Background:

• The aging global population presents a growing challenge for cardiovascular disease prevention.
• Lipid-lowering therapies (LLTs) are widely used but their application in the elderly, especially for primary prevention, is debated.
• Existing risk scores like SCORE2-OP aid risk stratification in older adults.

Purpose of the Study:

• To review current knowledge on LLT indications in elderly patients.
• To identify challenges in LLT use for cardiovascular prevention in this demographic.
• To discuss future directions for managing LLT in older adults.

Main Methods:

• Narrative review of existing literature.
• Examination of evidence-based medicine principles.
• Analysis of cardiovascular risk stratification tools for the elderly.

Main Results:

• Consensus exists for LLTs in secondary cardiovascular prevention in the elderly.
• Significant debate surrounds LLT use for primary prevention in older individuals.
• A key challenge is determining when the risks of LLTs outweigh their benefits.

Conclusions:

• Further guidance is needed to identify elderly patients who should discontinue LLT.
• Balancing benefits and risks of LLTs is critical in geriatric cardiovascular care.
• Future research should focus on optimizing LLT management in the elderly.